39%高关税，瑞士缘何成了特朗普“痛击对象”？

Core Viewpoint - The U.S. has imposed a 39% tariff on goods imported from Switzerland, marking a significant shift in trade relations and impacting Switzerland's economy, especially on its national holiday [1][2][4]. Group 1: Trade Relations - The U.S. trade deficit with Switzerland has surged, reaching nearly $50 billion in the first five months of the year, making Switzerland the fifth-largest trade partner for the U.S. [7] - Switzerland's exports to the U.S. account for approximately 19% of its total exports, highlighting the importance of the U.S. market for the Swiss economy [10]. - The U.S. Treasury has previously labeled Switzerland as a currency manipulator, indicating ongoing tensions regarding trade practices [12]. Group 2: Domestic Reactions in Switzerland - Following the tariff announcement, there has been significant criticism within Switzerland, particularly directed at Federal President Keller-Sutter for the perceived failure in negotiations [14][15]. - The pharmaceutical industry, which exports about 60% of its products to the U.S., has been blamed for straining U.S.-Swiss trade relations, with major companies like Novartis and Roche under scrutiny [17]. - There is a growing sentiment in Switzerland to reconsider its long-standing neutral stance and potentially strengthen ties with the EU, which has more favorable tariff rates with the U.S. [19]. Group 3: Economic Impact - If the tariffs remain unchanged, Switzerland's GDP could decline by approximately 0.6 percentage points, with more severe impacts if pharmaceuticals are excluded from tariff exemptions [21]. - The potential for tariffs on pharmaceuticals could reach as high as 200%, further exacerbating the economic challenges faced by the Swiss economy [21].